DRUG · Unmapped registry intervention
COTI2
Find medicine records ·
Find other trials using this name
Clinical trial
Study of COTI-2 as Monotherapy or Combination Therapy for the Treatment of Malignancies
NCT02433626
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
Cisplatin
Normalized identity: cisplatinView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedStudy of COTI-2 as Monotherapy or Combination Therapy for the Treatment of Malignancies
Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE1
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Ovarian Cancerverified · MONDO: ovarian cancer
Endometrial Cancerverified · MONDO: endometrial cancer
Cervical Cancerverified · MONDO: cervical cancer
Peritoneal Cancerverified · MONDO: peritoneum cancer
Colorectal Cancerverified · MONDO: colorectal cancer
Lung Cancerverified · MONDO: lung cancer
Interventions
COTI2DRUG
CisplatinDRUG · verified · RxNorm: cisplatin
Sponsors & collaborators
Critical Outcome Technologies Inc.lead sponsor
M.D. Anderson Cancer Centercollaborator
Northwestern Memorial Hospitalcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02433626 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.